|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||
| Current assets: | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Restricted cash | |||||||||||||||||
| Accounts receivable, net | |||||||||||||||||
| Inventories | |||||||||||||||||
| Contract assets | |||||||||||||||||
| Deposits, prepayments and other receivables | |||||||||||||||||
| Total current assets | |||||||||||||||||
| Non-current assets: | |||||||||||||||||
| Intangible assets, net | |||||||||||||||||
| Goodwill | |||||||||||||||||
| Construction in progress | |||||||||||||||||
| Plant and equipment, net | |||||||||||||||||
| Right of use assets, net | |||||||||||||||||
| Deferred tax assets | |||||||||||||||||
| Total non-current assets | |||||||||||||||||
| TOTAL ASSETS | |||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT) | |||||||||||||||||
| Current liabilities: | |||||||||||||||||
| Accounts payables | |||||||||||||||||
| Contract liabilities | |||||||||||||||||
| Accrued liabilities and other payables | |||||||||||||||||
| Due to related parties | |||||||||||||||||
| Related Party | |||||||||||||||||
| Total due to related parties | |||||||||||||||||
| Operating lease liabilities | |||||||||||||||||
| Amount due to first insurance funding | |||||||||||||||||
| Loan | |||||||||||||||||
| Total current liabilities | |||||||||||||||||
| Non-current liabilities | |||||||||||||||||
| Operating lease liabilities | |||||||||||||||||
| Deferred tax liabilities | |||||||||||||||||
| Total non-current liabilities | |||||||||||||||||
| TOTAL LIABILITIES | |||||||||||||||||
| SHAREHOLDERS’ EQUITY (DEFICIT) | |||||||||||||||||
| Series X Super Voting Preferred Stock, $0.0001 par value, 153,500 shares designated; 153,500 and 153,500 Series X shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively | |||||||||||||||||
| Series X Super Voting Preferred Stock | |||||||||||||||||
| Total series X Super Voting Preferred Stock, $0.0001 par value, 153,500 shares designated; 153,500 and 153,500 Series X shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively | |||||||||||||||||
| Common shares; $0.0001 par value, 50,000,000 shares authorized; 6,105,525 and 3,718,030 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively | |||||||||||||||||
| Subscription receivable | |||||||||||||||||
| Additional paid-in capital | |||||||||||||||||
| Less: Common shares held in treasury, at cost; 51,902 and 74,107 shares as of September 30, 2024 and December 31, 2023 | |||||||||||||||||
| Less: Preferred stock held in treasury, at cost; 150,000 and 150,000 shares at September 30, 2025 and December 31, 2024, respectively | |||||||||||||||||
| Less: Common shares held in treasury, at cost; 0 and 51,902 shares September 30, 2025 and December 31, 2024, respectively | |||||||||||||||||
| Accumulated other comprehensive income | |||||||||||||||||
| Accumulated deficit | |||||||||||||||||
| Total equity (deficit) attributable to Society Pass Incorporated | |||||||||||||||||
| Non-controlling interest | |||||||||||||||||
| TOTAL EQUITY (DEFICIT) | |||||||||||||||||
| TOTAL LIABILITIES AND EQUITY (DEFICIT) | |||||||||||||||||
Loading...
